Selective inhibitor of phosphatidylinositol 3-kinase-gamma
US10301304B2 · kind B2 · utility
1Cited by
1References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 25, 2014 |
| Grant date | May 28, 2019 |
| Priority date | — |
| Expiry date | Sep 25, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a compound useful as a selective inhibitor of PI3Kγ. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.